<DOC>
	<DOCNO>NCT01889654</DOCNO>
	<brief_summary>Lupus disease characterize production pathogenic autoantibody , participate end-organ damage . The phenotype B cell produce pathogenic autoantibody lupus patient today unknown . Antinucleosome antibodies characteristic lupus disease.This project propose detect antinucleosome B cell lupus patient analyse phenotype frequency .</brief_summary>
	<brief_title>Anti-nucleosome B Lymphocytes Lupus</brief_title>
	<detailed_description />
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<criteria>Inclusion criterion SLE patient : SLE patient : diagnostic base ACR criterion SLE patient produce seric antinucleosome antibody ( ELISA ) SLEDAI2K activity score : inferior 5 quiescent patient , superior 8 since least 2 month active patient Exclusion criterion SLE patient : Other autoimmune disease SLE Induced lupus Treatment corticosteroid &gt; 10mg/d ( prednisone ) quiescent patient Treatment corticosteroid &gt; 20mg/d ( prednisone ) active patient Oral immunosuppressive treatment last 6 month ( methotrexate , azathioprine , ciclosporine , mycophénolate mofétil ) patient , treatment last year cyclophosphamide monoclonal antibody ( rituximab , belimumab ) pour quiescent patient Disease modify B T lymphocyte function : primary immune deficiency , evolutive infection , chronic viral infection ( VIH particular ) , chemotherapy neoplasm antecedent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2014</verification_date>
</DOC>